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A B S T R A C T
In order to study left ventricular hypertrophy patterns in obese hypertensives, we ex-
amined 132 patients with essential hypertension by 2D, M-mode and Doppler echocar-
diography. The patients were classified in four comparable groups, corresponding to the
values of Quetelet’s body mass index (BMI) and grades of obesity. More obese hyper-
tensives had on average larger left ventricles with thicker walls and larger left atria
than less obese, or lean ones. Left ventricular mass increased significantly and progres-
sively with advancing grades of obesity, but relative wall thickness (wall thickness/cav-
ity size ratio) did not diminish.
Doppler echocardiography revealed significantly higher prevalence of left ventricu-
lar diastolic dysfunction among obese than among lean hypertensives.
In the second part of our study, we analyzed the subgroups defined by the severity of
hypertension and the age of the patients. The correlation of the indices of left ventricular
and left atrial hypertrophy with the BMI values was considerably better in the group of
moderate than in the group of mild hypertension. The r values were 0.62 vs. 0.22 for left
ventricular mass and 0.64 vs. 0.26 for left atrial dimension. The group of patients with
severe hypertension was characterized by left ventricular cavity enlargement in correla-
tion with increasing BMI values, but without corresponding left ventricular wall thick-
ening. So called left ventricular »eccentricity index«, as the reverse value of relative wall
thickness, correlated well (r = 0.76) with the BMI values. The indices of left ventricular
hypertrophy correlated with the BMI values slightly better in middle age groups than in
the groups of the youngest ( 30 years) or the eldest ( 61 years) hypertensives.
In conclusion, eccentric left ventricular hypertrophy does not seem to be a distinctive
feature of hypertensive heart disease in obesity. There is only some tendency toward the
»eccentricity« of left ventricular geometry which becomes more apparent in more severe
forms of hypertension, especially in very obese persons.
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Introduction
It has been stated that the obese hy-
pertensives are prone to the eccentric hy-
pertrophy of the left ventricle1–5. This is
in contrast to the lean hypertensives who
develop concentric left ventricular hyper-
trophy as the most typical feature of hy-
pertensive heart disease6–8. Eccentric hy-
pertrophy may be defined by an increase
in left ventricular mass due mainly to the
cavity enlargement without pronounced
thickening of the walls. At most, they are
thickened proportionally to the increase
in cavity size8,9. On the contrary, concen-
tric hypertrophy is characterized by left
ventricular wall thickening without in-
crease in cavity size8,9.
The assumption that eccentric left
ventricular hypertrophy is typical for
obese hypertensives is supported by the
observations that marked obesity induces
eccentric left ventricular hypertrophy
even in the absence of arterial hyperten-
sion. This can be explained by increases
in intravascular blood volume, cardiac
output and stroke volume, necessary to
meet metabolic demands of increased
mass of adipose tissue10,11.
These peculiarities of left ventricular
geometry and haemodynamics in obese
hypertensives are relevant for the choice
of antihypertensive drugs2. The question
arises: »Is the prevalence of eccentric hy-
pertrophy among obese hypertensives
distinctive enough to warrant specific
therapeutic approach?« Evidence on this
point is conflicting. We tried to throw lit-
tle bit more light upon the question rele-
vant for clinical practice: »Do obese hy-
pertensives with left ventricular hyper-
trophy really have eccentric, instead of
concentric hypertrophy?«
Patients and Methods
We examined 132 hypertensives by
two-dimensional, M-mode and Doppler
echocardiography. Among them were 71
males aged 53.11 12.55 years (mean
 SD) and 61 females aged 48.18 14.63
years. Corresponding values for the
whole group were 50.83 13.2 years. Al-
most all age groups were included. The
youngest patient was 17 and the eldest
90 years old, median value was 50 years.
All the patients were supposed to have
had essential hypertension on the basis of
generally accepted clinical and diagnostic
standards12. The patients with coronary
and valvular heart disease were excluded
from the study, as were the patients with
atrial fibrillation. Only three patients
had the signs of overt heart failure.
The severity of hypertension was as-
sessed according to the criteria of Julius
and Marinkovi}13,14. It was classified as
mild, moderate, or severe hypertension.
The values of Quetelet’s body mass in-
dex (BMI) of weight/height2, expressed in
kg/m2 and relative body mass (RBM) ex-
pressed in the percentages of ideal weight
(»weight goal«), were estimated for each
patient15. The patients were classified as:
lean hypertensives (BMI  24.9 kg/m2,
RBM  110%), mildly obese hypertensives
(BMI 25–27 kg/m2, RBM 111–120%),
moderately obese hypertensives (BMI
27.1–31.5 kg/m2, RBM 121–140%) and
extremely obese hypertensives (BMI >
31.5 kg/m2, RBM > 140%). Ideal body
weight (RBM 100%) corresponded to the
BMI value of 22.7 kg/m2 for males and
26.9 kg/m2 for females. The RBM value
for 40% overweight (RBM 140%) corre-
sponded to the BMI values of 31.8 and
31.4 kg/m2 for males and females respec-
tively15.
All the groups were mutually compa-
rable in respect to the age and the sever-
ity of hypertension: the analysis of vari-
ance did not reveal any significant diffe-
rence between the groups. The proportion
of women in the group of markedly obese
hypertensives was significantly higher
than in the groups of lean and mildly
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obese hypertensives ( 2 test). However,
there was no significant difference be-
tween the lean hypertensives and obese
hypertensives altogether, so that the
groups were also comparable in respect to
sex distribution.
The patients were not selected. They
were included in the study as they were
examined in our outpatient's depart-
ment, providing that they had essential
hypertension and no other cardiac dis-
ease, excepting hypertensive heart dis-
ease. Relatively high proportion of obese
patients probably reflected the nutritio-
nal status of the hypertensives in our lo-
cal population. The evaluation of the pa-
tients and diagnostic procedures were
performed in our outpatient's depart-
ment. The only exceptions were a few pa-
tients with severe hypertension who were
admitted to our hospital department be-
cause of intensive treatment and complex
diagnostic procedures.
Echocardiographic examinations were
performed by Diasonics CV 400 echocar-
diographic equipment. Heart dimensions
were measured in at least three consecu-
tive cardiac cycles, according to the rec-
ommendations of European16 and Ameri-
can17 echocardiographic societies. The
values of left ventricular internal dia-
stolic dimension (LVIDd), diastolic left
ventricular posterior wall thickness
(PWTh), diastolic interventricular sep-
tum thickness (IVSTh), left ventricular
mass, LVIDd/IVSTh + PWTh ratio and
left atrial dimensions were analyzed in
respect to the grades of obesity and hy-
pertension. The age of the patient was
taken into the account. Left ventricular
mass was calculated from M-mode left
ventricular dimensions, using Penn con-
vention equation18–21.
The ratio LVIDd/PWTh + IVSTh could
be called »the index of left ventricular ec-
centricity« and it actually represents the
reciprocal value of the relative left ven-
tricular wall thickness22,23.
Systolic left ventricular function was
represented by ejection fraction. It was
preferred because of its widespread clini-
cal use, although some other echocardio-
graphic indices might be more correct
from the aspect of methodology24. Left
ventricular ejection fraction was calcu-
lated from left ventricular diastolic
(LVIDd) and systolic (LVIDs) dimensions,
using Teicholz’s equation25, but it was
controlled by two-dimensional methods:
Simpson’s and Dodge’s (»area-len-
gth«)24,36–31. The overlapping of M-mode
and two-dimensional left ventricular eje-
ction fractions' values was satisfactory, so
that repeated estimation and correction
were rarely needed.
Some aspects of left ventricular dia-
stolic function and filling were studied by
comparing transmitral peak flow veloci-
ties in early (PFVE) and late (PFVA) dias-
tole24,32–34. Pulsed Doppler sample volume
was placed in the mitral valve orifice, at
the level of mitral valve ring. Diastolic
left ventricular dysfunction was suspec-
ted if PFVE/PFVA ratio was more than
1.5, or if its reciprocal value PFVE/PFVA
was less than 0.66. Markedly decreased
early and mid-diastolic deceleration rate
(represented by the slope following PFVE)
was considered as an additional clue for
the presence of left ventricular diastolic
dysfunction, useful in dubious cases. Sim-
ilar meaning was ascribed to the very
slow increase in M-mode left ventricular
dimension in early diastole, together with
its marked increase after atrial contrac-
tion in late diastole24.
In 98 patients with satisfactory su-
prasternal approach, cardiac output was
estimated by Doppler method, using 2.25
MHz continuous wave nonimageing
transducer (so called Pedoff probe). The
equation used for the calculation of car-
diac output was: SV HR = FVI CSA HR,
where SV is stroke volume, HR heart
rate, FVI flow velocity integral in ascend-
ing aorta from the suprasternal approach
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and CSA cross sectional area at the level
of aortic valve ring (annulus). Cross sec-
tional area was calculated from the stan-
dard circle area equation r2p, where r is
the half value of aortic annulus diameter,
measured from the two-dimensional pa-
rasternal long axis approach24,35.
The statistical significance of differ-
ences between the groups was tested by
variance analysis with Newman Keul’s
comparisons. The only exception was the
analysis of left ventricular diastolic dys-
function, where c2 test was used instead.
Linear correlations were expressed as
Pearson’s correlation coefficients (r). Com-
puter program »Quickstatt« was used for
statistical analysis.
Results
Very small increments of LVIDd were
noted, along with increasing grades of
obesity, represented by BMI values (Fig-
ure 1). The differences were small and
statistically insignificant, but the trend
was steady. On the average, more obese
hypertensives had slightly larger left
ventricles than their less obese, or lean
counterparts.
Obese hypertensives had significantly
thicker left ventricular walls, represen-
ted by the IVSTh and PWTh values, than
lean hypertensives (Figure 2). However,
no differences between the groups with
various degrees of obesity were noted.
The increase in left ventricular mass
among the obese hypertensives, in re-
spect to their less obese counterparts was
highly significant (Figure 3). However,
the differences between the subgroups of
obese hypertensives were small. Extre-
mely obese hypertensives had slightly
higher left ventricular mass values than
their less obese counterparts.
The ratio LVIDd/PWTh + IVSTh (»left
ventricular eccentricity index«) was slightly
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Fig. 1. Left ventricular (LVIDd) and left atrial (LA) diameter in the groups of hypertensives defined
by the BMI values, from lean and mildly obese to moderately and extremely obese hypertensives.
The group of lean hypertensives comprised 30 patients with LVIDd 4.780.55 cm (meanSD) and
LA 3.460.55 cm The respective values were 4.940.61 cm and 3.820.50 cm for 25 mildly obese,
5.020.51 cm and 3.810.67 cm for 42 moderately obese, as well as 5.09  0.54 cm and 3.400.51 cm
for 35 extremely obese hypertensives. The differences between the LVIDd values were not significant,
but the level of statistical significance was reached for LA values (p < 0.05, analysis of variance).
and insignificantly higher in the group of
lean hypertensives than in the subgroups
of obese hypertensives (Figure 4). The
mean values in the subgroups of obese
hypertensives were almost identical.
Left ventricular ejection fraction val-
ues were normal in all the groups, being
slightly and insignificantly higher among
the lean hypertensives than among their
less obese counterparts (Figure 5).
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Fig. 2. Interventricular septum (IVSTh) and posterior left ventricular wall thickness (PWTh) in the
groups of lean (11.772.22 mm vs. 10.92.54 mm), mildly obese (13.793.64 mm vs. 13.0682.45
mm), moderately obese (13.332.24 mm vs. 12.941.88 mm) and extremely obese hypertensives
(13.392.29 mm vs. 12.941.93 mm). The differences were statisticaly significant (p < 0.05 for
IVSTh values and p < 0.001 for PWTh values according to the analysis of variance).
Fig. 3. Degree of obesity and left ventricular mass : 249.2762.62 g in the group of lean hyperten-
sives, 329.0895.97 g for mildly obese, 325.2189.86 g for moderately obese and 338.74107.38 g
for extremely obese hypertensives. The differences were highly significant (p < 0.001, analysis of
variance).
The prevalence of left ventricular dia-
stolic dysfunction was significantly hig-
her among the obese, than among the
lean hypertensives (Figure 6). It was two
times higher in the group of extremely
obese hypertensives than in the group of
lean hypertensives.
Left atrial dimension was significan-
tly bigger in the group of obese hyper-
tensives than in the groups of their non-
obese counterparts (Figure 1). The differ-
ences between the subgroups of obese
hypertensives were small, but on aver-
age, extremely obese hypertensives had
the largest atria.
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Fig. 4. Degree of obesity and »eccentricity index«: 2.1240.476 for lean, 1.9340.461 for mildly
obese, 19310.351 for moderately obese and 1.9300.385 for extremely obese hypertensives. The dif-
ferences were not significant.
Fig. 5. Degree of obesity and ejection fraction: 74.834.62% for lean, 71.126.84% for mildly obese,
68.6714.24% for moderately obese and 71.668.30% for extremely obese hypertensives. The differ-
ences were not significant.
In the group of 98 hypertensives, the
values of cardiac output measured by
Doppler method were very similar in all
the groups arranged about their BMI val-
ues and grades of obesity (Figure 7).
Corresponding to the definition, cardiac
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Fig. 6. Degree of obesity and left ventricular diastolic dysfunction: 23% for lean hypertensives had
the signs of left ventricular diastolic dysfunction (7 out of 30). The respective values were 36& (9
out of 25) for mildly obese, 29% (12 out of 42) for moderately obese and 57% (20 out of 30) for ex-
tremely obese hypertensives. The differences were significant (p < 0.05, 2 test).
Fig. 7. Degree of obesity and cardiac output/cardiac index values in 98 hypertensives. In the group
of 26 lean hypertensives, cardiac output was 5.851.44 l/min (mean value±SD) with cardiac index
of 3.360.92 l/min/m2. The group of mildly obese hypertensives included 16 patients with the car-
diac output of 5.341.23 l/min and cardiac index of 2.840.61 l/min/m2. The respective values for
25 moderately obese hypertensives were 5.291.40 l/min and 2.830.60 l/min/m2, followed by 29
extremely obese hypertensives with 5.521.32 l/min and 2.690.59 l/min/m2. The differences in
cardiac output were insignificant, while all the groups of obese hypertensives had significantly
lower values of cardiac output than the group of lean hypertensives (p < 0.05, analysis of variance).
index values were considerably lower in
obese than in lean hypertensives (Figure
7). However, the differences did not reach
the level of statistical significance. Unex-
pectedly, the mean cardiac index values
did not diminish further, proportionally
to the increasing grades of obesity.
The majority of aforementioned car-
diac morphometric and functional para-
meters were analyzed by linear regres-
sion procedures in the whole group of
hypertensives. Morphometric indices we-
re also analyzed in the subgroups defined
by the age of the patient and by severity
of hypertension.
The data for the whole group are pre-
sented in the Table 1. Evidently, all the
morphometric indices (LVIDd, PWTh, LV
mass and LA), excepting IVSTh and
LVIDd/PWTh + IVSTh, correlated signifi-
cantly with the BMI values, although the
Pearson’s correlation coefficients were
very modest. Functional indices, i.e., car-
diac output and cardiac index did not cor-
relate with the BMI values.
Analysis of the subgroups regarding
the severity of hypertension is presented
in the Table 2. Obviously, the correlation
of the morphometric indices with the
BMI values was much better in the sub-
group with moderate hypertension than
in the one with mild hypertension. The
subgroup of the patients with severe hy-
pertension was small, so that even quite
high correlation coefficients did not reach
the level of statistical significance. The
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TABLE 1
THE CORRELATIONS OF MORPHOMETRIC AND HAEMODYNAMICAL INDICES
WITH THE BMI VALUES
No. of pts. r p
LVIDd 132 0.1938 0.026*
LV mass 132 0.2823 0.001*
LA 132 0.2472 0.004*
PWTh 132 0.2598 0.003*
IVSTh 132 0.1428 0.102
LVIDd/IVSTh+PWTh 132 –0.1366 0.118
Cardiac output 98 0.0931 0.362
Cardiac index 98 0.0964 0.345
Asterisk (*) denotes statistical significance with p value < 0.05.
TABLE 2
CORRELATIONS OF THE MORPHOMETRIC INDICES WITH THE BMI VALUES IN THE
SUBGROUPS DEFINED BY THE SEVERITY OF HYPERTENSION
hypertension mild moderate severe
n r p n r p n r p
LVIDd 93 0.1502 0.151 35 0.6656 0.000* 5 0.6370 0.248
LV mass 93 0.2167 0.037* 35 0.6199 0.000* 5 0.0760 0.904
LA 93 0.2590 0.012* 35 0.6360 0.000* 5 0.1320 0.832
PWTh 93 0.2414 0.020* 35 0.7018 0.000* 5 –0.2674 0.664
IVSTh 93 0.1212 0.247 35 0.5892 0.000* 5 –0.7061 0.183
Asterisk (*) denotes statistical significance with p value < 0.05.
best correlation (r = 0.76) was between
the LVIDd/PWTh + IVSTh ratio and the
BMI, but the significance was borderline
(p = 0.05). It is depicted separately in the
Figure 8, while the characteristic regres-
sion line for the BMI/LVIDd relation in
the subgroup of moderate hypertensives
is presented in the Figure 9.
The Table 3 presents the analysis of
the morphometric indices in relation to
the BMI values in the subgroups arran-
ged according to the age. The level of sta-
tistical significance was reached only for
posterior wall thickness in the fourth, left
atrial dimension in the fifth and left ven-
tricular mass in the sixth decade of life.
The relationship between left atrial size
and BMI in the forth decade of life is pre-
sented in the Figure 10.
Discussion
The principal questions demanding
answers in our study might be defined as
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Fig. 8. The correlation between the BMI and »eccentricity index« values in the
group of severe hypertension.
Fig. 9. The correlation between the BMI and LVIDd values in the group
of moderate hypertension.
follows: »Do obese hypertensives really
develop eccentric left ventricular hyper-
trophy as a typical form of hypertensive
heart disease?«. Are they distinctively
different from lean hypertensives who
usually develop concentric left ventricu-
lar hypertrophy? Could be assumed with
reasonable certainty that left ventricular
hypertrophy in an obese hypertensive
would be eccentric, instead of concentric
hypertrophy?«
Intravascular volume and cardiac out-
put are increased in obese persons (com-
pared with lean ones) to fulfill the meta-
bolic demands of increased adipose tissue
mass10,11. Cardiac index is actually de-
creased1,10,36. As no essential changes in
the basic heart rate are usually present,
the principal determinant of the increase
in cardiac output has to be an increase in
stroke volume. It is due to increased left
ventricular filling, providing that there
are no substantial changes in myocardial
contractility and peripheral vascular re-
sistance. In the circumstances of long-
standing increase in left ventricular fill-
ing, development of eccentric left ventric-
ular hypertrophy, seems to be a logical
consequence10,11. It is presumably due to
the replication of sarcomeres in length,
perhaps with some myocardial cell slip-
page9.
Classical post-mortem studies confir-
med that eccentric left ventricular hyper-
trophy is typical for very obese persons10.
Echocardiographic studies demonstrated
that on average, obese persons had larger
left ventricles with thicker walls and big-
ger stroke volumes than non-obese con-
trols37,38. This was especially true in the
obesity of visceral type and long-standing
duration37,38. However, the data on left
ventricular geometry were conflicting.
Until recently, the view prevailed that
the increase in left ventricular mass in
obese persons was mainly due to the cav-
ity enlargement39,40. The echocardiogra-
phic evidence supporting this view was
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TABLE 3
THE CORRELATIONS BETWEEN THE LEFT VENTRICULAR AND LEFT ATRIAL MORPHOMETRIC
INDICES WITH THE BMI VALUES IN THE DIFFERENT AGE GROUPS
age  30 31–40 41–50
n r p n r p n r p
LVIDd 9 0.0807 0.837 14 0.3865 0.172 46 0.1628 0.280
LV mass 9 0.2366 0.540 14 0.4462 0.110 46 0.2580 0.083
LA 9 0.5787 0.103 14 0.0666 0.821 46 0.4467 0.002*
PWTh 9 0.1536 0.693 14 0.5540 0.040* 46 0.2645 0.076
IVSTh 9 0.3660 0.333 14 0.0902 0.759 46 0.1245 0.410
age 51–60  61
n r p n r p
LVIDd 35 0.2820 0.101 28 –0.0010 0.996
LV mass 35 0.4290 0.010* 28 0.0240 0.910
LA 35 0.2837 0.099 28 0.1415 0.473
PWTh 35 0.3195 0.061 28 0.1070 0.588
IVSTh 35 0.3014 0.078 28 0.0175 0.930
Asterisk (*) denotes statistical significance with p value < 0.05.
not very convincing for us. The overlap-
ping of cardiac dimensions between the
groups of obese and lean persons was
substantial, despite the statistical signifi-
cance of differences. Moreover, the data
published after the termination of our
study indicated that the relative wall
thickness might be actually increased in
obese persons41.
The next step in our deduction is a
shift from obese normotensives to obese
hypertensives. Obesity and arterial hy-
pertension have much in common, from
epidemiological features and physiologi-
cal derangements to the clinical, thera-
peutic and prognostic aspects4,5,10,42,43. In-
sulin resistance, a common metabolic
denominator of both conditions has been
much discussed lately44–47. In the clinical
practice, both conditions can be found in
the some patient so often, that they al-
most form a third entity: an obese hyper-
tensive. The effects of hypertension and
obesity on the increase in left ventricular
mass are additive, both favoring the de-
velopment of left ventricular hypertro-
phy48–50.
The shape of the hypertrophied left
ventricle has significant clinical implica-
tions. Not a long time ago, a distingui-
shed author recommended diuretics for
the basic antihypertensive treatment of
obese persons, supposing that volume
overload and eccentric left ventricular
hypertrophy were the main features of
the condition2,39,51. However, this appears
to be a matter of controversy. While the
most authors supported the common be-
lief that left ventricular hypertrophy in
obese hypertensives is mostly eccen-
tric39,52, some have recently found that
concentric one is more common50.
Our results suggest that eccentric left
ventricular hypertrophy is not very typi-
cal for obese hypertensives in general. On
average, they may have somewhat larger
left ventricles than non-obese hyperten-
sives, but the features of cavity size are
not distinctive enough. It cannot be pre-
sumed without diagnostic (mainly echo-
cardiographic) evaluation that particular
hypertensive and obese hypertensive has
eccentric, instead of concentric left ven-
tricular hypertrophy53–55. Making pre-
sumptions on the left ventricular geome-
try just because of the patient’s obesity
does not seem to be justified, especially if
therapeutic consequences are anticipa-
ted56,57.
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Fig. 10. The correlation between the BMI values and left atrial size in the fourth decade of life.
Left ventricular wall stress is espe-
cially high in hypertensives with dilated
left ventricle, without sufficient wall
thickening58,59. The resulting increase in
myocardial oxygen consumption with the
metabolic energy demand-supply imbal-
ance may cause myocardial failure6,60,61.
In such circumstances, the effects of
antihypertensive drugs that may cause
regression of the left ventricular hyper-
trophy with wall thinning may be unfa-
vorable62–64. The bouts of hypertension
after cessation of therapy may be delete-
rious. Therefore, some authors regarded
eccentric left ventricular hypertrophy in
arterial hypertension as an unfavorable
condition with predisposition to systolic
heart failure58. Others pointed to the spe-
cific adverse aspects of concentric left
ventricular hypertrophy50,65,66. Left ven-
tricular filling patterns are presumably
different in hypertensives with concen-
tric and eccentric left ventricular hyper-
trophy23.
The adverse prognostic significance of
left ventricular hypertrophy is well de-
fined65,67–69. The eccentric hypertrophy in
hypertensives may be in some aspects
even more ominous than its concentric
counterpart47.
The lack of correlation between left
ventricular dimensions and the BMI val-
ues is probably not surprising. »Pure«
haemodynamical models are rare in clini-
cal studies. »Pure« obesity may be charac-
terized by left ventricular volume over-
load, but the features of established
essential arterial hypertension are the
decreases of intravascular volume and
cardiac output with an increase in pe-
ripheral vascular resistance1,2,70. Besides
of this, haemodynamical features are not
the only determinants of left ventricular
hypertrophy. Factors influencing the type
and extent of left ventricular hypertrophy
are manifold with complex interac-
tions5,70–74. Physical activity also influ-
ences left ventricular mass75 and the
form of left ventricular hypertrophy. The
example is physiological left ventricular
hypertrophy in athletes76–84. Long distan-
ce runners and swimmers develop eccen-
tric hypertrophy, while weight lifters are
prone to the concentric hypertrophy77.
Presumably, not all of our hypertensive
patients were devoid of significant physi-
cal activity.
Relative wall thickness is not increa-
sed in eccentric left ventricular hypertro-
phy. In our study, it was slightly higher in
obese than in non-obese hypertensives,
while the eccentricity index was little bit
lower. This was not surprising consider-
ing some published data41 and the pre-
dominance of mild hypertension in our
study. Left ventricular dimensions in the
group of non-obese hypertensives were
not in the range of hypertrophy.
This explanation was confirmed in
part by the analysis of the subgroups.
More obese patients with severe arterial
hypertension had more pronounced »ec-
centricity« of the left ventricular hyper-
trophy than their less obese counter-
parts. The correlation’s between left ven-
tricular and left atrial dimensions with
the BMI values were much better among
the patients with moderate and severe
hypertension than in the subgroup with
mild hypertension. The influence of mild
hypertension on left ventricular hyper-
trophy and geometry may be weak85,86,
while more severe forms of hypertension
predispose to the eccentric hypertrophy
development and left atrial enlargement
in markedly obese persons. Previous data
on this point are conflicting50,85,86. Moder-
ate and severe forms of arterial hyperten-
sion in obese people must not be simply
identified with advanced stages of essen-
tial arterial hypertension characterized
by intravascular volume decrease and
high peripheral vascular resistance2,87.
In our study, left ventricular diastolic
dimension and mass correlated with BMI
values somewhat better in middle aged,
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than in younger or elderly hypertensives.
The correlations for all left ventricular
and left atrial morphometric indices were
especially poor among the patients over
sixty years of age. The temporal patterns
of arterial hypertension and obesity de-
velopment in our patients were not de-
fined precisely enough to allow the exact
analysis of their mutual relationship
through the process of aging88,89.
It was found earlier that eccentric left
ventricular hypertrophy is uncommon in
persons under 50 years of age, but it is
not rare in elderly hypertensives who are
over 605,90. However, this refers not to the
particular group of predominantly obese
hypertensives without coronary heart di-
sease that was analyzed in ours study.
The finding that left ventricular filling
impairment paralleled with advancing
grades of obesity in our hypertensive pa-
tients was not surprising. Obesity can be
associated with impaired left ventricular
diastolic function even in normotensive
subjects9,91.
Cardiac index values were lower in
our obese hypertensives than in their
non-obese counterparts, as expected4,10,11.
Unexpectedly, cardiac output values did
not rise with advancing obesity. This was
not much surprising, considering very
small increments in left ventricular dia-
stolic dimensions, slight decrease in ejec-
tion fraction and from other point of view,
limited accuracy of Doppler cardiac out-
put estimation35,92. Therefore, we aban-
doned idea of cardiac output analysis in
the subgroups.
Our study is limited by a few possible
shortcomings. One of them is the lack of a
control group of obese normotensives.
However, our study was basically desig-
ned to analyze the patterns of left ven-
tricular hypertrophy in obese hyperten-
sives, contrasted with the hypertrophy
patterns in non-obese hypertensives. The
introduction of the second (obese normo-
tensives), or even the third (lean normo-
tensives) control group may be confusing.
We are aware that Quetelet’s body
mass index is far from being the optimal
indicator of body fat content and distribu-
tion. There are much more accurate me-
thods nowadays93,94. However, more reli-
able techniques are also more expensive,
possibly with some irradiation (CT scans).
In our future studies, we shall include at
least waist/hip ratio as a simple index of
central obesity39.
Our patients were not distributed
evenly in the subgroups concerning the
severity of hypertension. Mild hyperten-
sives prevailed, moderate hypertension
was quite frequent, while only a few pa-
tients had severe arterial hypertension.
This probably reflects the prevalence of
various grades of arterial hypertension in
clinical practice95,96. The selection in fa-
vor of more severe forms of hypertension
would bias the study. Nevertheless, the
subgroup with severe hypertension was
too small and some further investigation
of the whole problem »on the large scale«
would be desirable.
The groups of lean and obese hyper-
tensives were comparable, with similar
proportions of both sexes. The analysis of
sexual differences would surpass the sco-
pe of our present study, but it may be the
aim of our future studies. Sexual dimor-
phism is expected in normal hearts from
the puberty97–100. On average, males have
somewhat larger left ventricular mass
than females, even if normalized to the
body surface area58,72. In hypertensives,
premenopausal women are less prone to
the left ventricular hypertrophy than
men72. Thus, the preponderance of wo-
men in the group with severe hyperten-
sion may have only diminished the extent
of hypertrophy.
Our study was lacking the follow-up of
the patients. Such approach would be
very complex and probably surpass our
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basic aim, defined by the title of this arti-
cle. Our present study might be viewed
upon as an impetus for the future longi-
tudinal studies.
Our estimation of left ventricular dia-
stolic function was incomplete, limited to
the methodology used in everyday clinical
routine. A complete estimation would in-
clude isovolumic relaxation time measu-
rements and more elaborate analysis of
left ventricular filling23,24,32–34,101–104. How-
ever, this would surpass the basic aim of
the study. The E/A ratio, as a single index
of diastolic performance has become the
most popular method for clinical detec-
tion of left ventricular diastolic dysfunc-
tion34. Our E/A criterion f or diastolic dys-
function was rigorous to avoid false
positive estimations and to overcome the
uncertainties due to insufficient stan-
dardization of normal values and age in-
fluence105–108. The point of evaluation was
not the estimation of the true diastolic
dysfunction prevalence, but its relation to
the grades of obesity. Our methodology
was probably not free of some pitfalls
that were not recognized at the time of
initiation of the study. Some of them
could have been avoided by the analysis
of pulmonary venous flow velocity pat-
terns34.
Turning back to our basic question,
whether obese hypertensives in clinical
practice usually develop eccentric, in-
stead of concentric left ventricular hyper-
trophy, we could probably offer some an-
swers. There is a tendency in obese
hypertensives towards the eccentric left
ventricular hypertrophy, however, it is
mostly weak and non discriminative.
This is especially true for the mild hyper-
tensives. In the cases of moderate and se-
vere hypertension, the tendency towards
eccentric left ventricular hypertrophy ap-
pears to be considerably more pronoun-
ced. The severity of arterial hypertension
appears to be a major determinant for the
left ventricle and left atrium enlargement
in obese hypertensives. The ideal candi-
date for eccentric left ventricular hyper-
trophy appears to be a markedly obese,
middle aged person with moderate, or se-
vere arterial hypertension. It appears
that eccentric left ventricular hypertro-
phy is not very typical for the most of
obese hypertensives. However, it is quite
common in certain subgroups whose cha-
racteristics we tried to define in this stu-
dy.
Updating this manuscript since the
time of submission, we have to comment
a new large Norwegian study on left ven-
tricular hypertrophy in population100.
BMI and systolic pressure were confir-
med as strong determinants of left ven-
tricular mass, while the influence of age
was remarkable only in persons with hy-
pertensive, or some other heart disease.
Left ventricular geometry in obese hyper-
tensives was not analyzed. It remains the
matter of controversy which we tried to
elucidate by our modest contribution.
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DA LI JE HIPERTROFIJA LIJEVE KLIJETKE U PRETILIH
HIPERTONI^ARA: UISTINU EKSCENTRI^NA?
(EHOKARDIOGRAFSKA STUDIJA)
S A @ E T A K
U studiji oblika hipertrofije lijeve klijetke u pretilih hipertoni~ara, pregledali smo
132 bolesnika dvodimenzionalnom, M-mode i Doppler ehokardiografijom. Ispitanici su
podijeljeni u ~etiri podjednake skupine prema vrijednostima Queteletovog indeksa tje-
lesne mase i stupnjevima pretilosti. Izrazitije pretili hipertoni~ari imali su u prosjeku
malo ve}u lijevu klijetku s debljim stijenkama i ve}i lijevi atrij nego manje pretili i
mr{avi hipertoni~ari. Masa lijevog ventrikula se pove}avala usporedo s pove}anjem
stupnja pretilosti, ali se relativna debljina stijenke (omjer debljine stijenke i veli~ine
ventrikula) nije smanjivala.
Doppler ehokardiografija je pokazala zna~ajno ve}u u~estalost dijastoli~ke disfunk-
cije lijeve klijetke me|u pretilim, negoli me|u mr{avim hipertoni~arima.
U drugom dijelu studije, analizirali smo podskupine definirane te`inom hiperten-
zije i dobi bolesnika. Korelacija pokazatelja hipertrofije lijeve klijetke i pretklijetke s
vrijednostima Queteletovog indeksa je bila znatno bolja u skupini s umjerenom, nego li
u skupini s blagom hipertenzijom. Vrijednosti koeficijenta r su bile 0,62 i 0,22 za masu
lijeve klijetke te 0,64 i 0,26 za promjer lijevog atrija. Skupina bolesnika s te{kom hiper-
tenzijom isticala se pove}anjem {upljine lijeve klijetke, usporedo s pove}anjem vrijed-
nosti Queteletovog indeksa, ali bez odgovaraju}eg zadebljanja stijenke. Tzv. indeks
ekscentri~nosti, kao recipro~na vrijednost relativne debljine stijenke lijeve klijetke, do-
bro je korelirao s Queteletovim indeksom (r = 0,76). Pokazatelji hipertrofije lijeve kli-
jetke su malo bolje korelirali s Queteletovim indeksom u srednjim dobnim skupinama,
nego u skupinama najmla|ih ( 30 g) i najstarijih ( 60 g) hipertoni~ara.
U zaklju~ku, ne ~ini se da je ekscentri~na hipertrofija lijeve klijetke karakteristi~na
osobina hipertenzivne bolesti srca u pretilih. Samo je nazna~ena tendencija »ekscen-
tri~nosti« geometrije lijevog ventrikula koja postaje izrazitija u te`im oblicima hiper-
tenzije, posebno u vrlo pretilih osoba.
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